| Dylan Hershkowitz, MD | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-0000 | |
| Not Available |
| Full Name | Dylan Hershkowitz |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 7 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922538644 | NPI | - | NPPES |
| MD17074 | Other | RI | STATE MEDICAL LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist Kazuhide Sato and colleagues tested the treatment and published their findings in the journal Cells.
The Wall Street Journal reports on how a number of policies and market forces are combining to put added pressure on rural hospitals. Meanwhile, other news outlets report on the challenge of making the health system affordable and the health law's new options for pregnant women.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Future Science OA, the inaugural gold open access journal from Future Science Group, has demonstrated its quality and commitment to openness in being accepted for indexing by the Database of Open Access Journals (DOAJ). In addition, it has been awarded the DOAJ seal, which is awarded to those journals that achieve a high level of openness, adhere to best publishing practice and have high publishing standards.
› Verified 3 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist Kazuhide Sato and colleagues tested the treatment and published their findings in the journal Cells.
The Wall Street Journal reports on how a number of policies and market forces are combining to put added pressure on rural hospitals. Meanwhile, other news outlets report on the challenge of making the health system affordable and the health law's new options for pregnant women.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Future Science OA, the inaugural gold open access journal from Future Science Group, has demonstrated its quality and commitment to openness in being accepted for indexing by the Database of Open Access Journals (DOAJ). In addition, it has been awarded the DOAJ seal, which is awarded to those journals that achieve a high level of openness, adhere to best publishing practice and have high publishing standards.
› Verified 3 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist Kazuhide Sato and colleagues tested the treatment and published their findings in the journal Cells.
The Wall Street Journal reports on how a number of policies and market forces are combining to put added pressure on rural hospitals. Meanwhile, other news outlets report on the challenge of making the health system affordable and the health law's new options for pregnant women.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Future Science OA, the inaugural gold open access journal from Future Science Group, has demonstrated its quality and commitment to openness in being accepted for indexing by the Database of Open Access Journals (DOAJ). In addition, it has been awarded the DOAJ seal, which is awarded to those journals that achieve a high level of openness, adhere to best publishing practice and have high publishing standards.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dylan Hershkowitz, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-0000 | Dylan Hershkowitz, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-0000 |
News Archive
Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist Kazuhide Sato and colleagues tested the treatment and published their findings in the journal Cells.
The Wall Street Journal reports on how a number of policies and market forces are combining to put added pressure on rural hospitals. Meanwhile, other news outlets report on the challenge of making the health system affordable and the health law's new options for pregnant women.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Future Science OA, the inaugural gold open access journal from Future Science Group, has demonstrated its quality and commitment to openness in being accepted for indexing by the Database of Open Access Journals (DOAJ). In addition, it has been awarded the DOAJ seal, which is awarded to those journals that achieve a high level of openness, adhere to best publishing practice and have high publishing standards.
› Verified 3 days ago
Rebecca Burch, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4589 | |
Dr. Dhruv Shah, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Judith L Lewis, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Avenue, Fletcher Allen Health Care, Burlington, VT 05401 Phone: 804-847-2791 Fax: 802-847-2733 | |
Ms. Laura Lynn Sponseller, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Fahc Department Of Psychiatry, Patrick 4, Burlington, VT 05401 Phone: 802-829-9645 | |
Lisa Deuel Baker, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4589 | |
Dr. Robert A Pierattini, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4560 Fax: 802-847-8747 | |
Dr. Edward George Boyer Iv, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4589 |